GlassScriptPhysician profile
Ashley G Mayer
NPI 1568690949
$3,304.53
in general payments reported to CMS, 2019-2025
27 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $267 · 2021: $453 · 2022: $439 · 2023: $234 · 2024: $486 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300 · Long Term Medical Supply Or Device Loan: $87.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.61 |
| Long Term Medical Supply Or Device Loan | $87.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $740.06 | 2019-2025 | Grafix, Stravix, Oasis |
| Integra Lifesciences Corporation | $533.08 | 2019-2025 | Tenoglide, Micromatrix |
| Melinta Therapeutics, LLC | $323.91 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $199.48 | 2020-2025 | Nuzyra |
| Ibsa Pharma INC. | $145.72 | 2023-2024 | Licart, Tirosint, Licart |
| Depuy Synthes Sales INC. | $122.54 | 2025 | Motoband, Minibunion |
| Ani Pharmaceuticals, INC. | $117.69 | 2025 | Purified Cortrophin Gel |
| Acumed LLC | $116.88 | 2024-2025 | Osteomed, Acumed, Acumed |
| Lifenet Health | $115.45 | 2024 | Theragenesis Wound Matrix |
| Horizon Therapeutics Plc | $103.63 | 2021-2022 | |
| Tactile Systems Technology INC | $100.05 | 2019-2021 | |
| Osiris Therapeutics INC. | $99.58 | 2019 | |
| Tei Medical INC. | $87.53 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $84.25 | 2022-2023 | Seglentis |
| Organogenesis INC. | $79.03 | 2019-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $54.30 | 2022 | |
| Hartmann USA, INC. | $46.88 | 2021-2022 | |
| Averitas Pharma INC. | $38.92 | 2025 | Qutenza |
| Amgen INC. | $31.39 | 2024 | Krystexxa |
| Stryker Corporation | $29.12 | 2025 | Prostep Mica |
| Kerecis Limited | $23.38 | 2019 | |
| Bioventus LLC | $23.34 | 2023 | |
| Innovation Technologies INC | $23.23 | 2021 | |
| Osteomed LLC | $21.56 | 2022 | |
| Medtronic, INC. | $15.92 | 2023 | Closurefast |
| Zimmer Biomet Holdings, INC. | $14.61 | 2020 | |
| Triad Life Sciences INC. | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.